Some aspects of thyroid dysfunction in thalassemia major patients with severe iron overload

被引:0
|
作者
Rindang, Cynthia K. [1 ]
Batubara, Jose R. L. [1 ]
Amalia, Pustika [1 ]
Satari, Hindra [1 ]
机构
[1] Univ Indonesia, Cipto Mangunkusumo Hosp, Med Sch, Dept Child Hlth, Jl Salemba 6, Jakarta, Indonesia
关键词
thalassemia major; endocrine; primary hypothyroidism; iron overload; iron chelation therapy;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Severe iron overload due to recurrent transfusions for chronic anemia and inadequate iron chelation therapy in thalassemia major patients result in various complications, including hypothyroidism. Currently, there has been no data on the prevalence of hypothyroidism in thalassemia major patients at the Thalassemia Centers, Department of Child Health, Cipto Mangunkusumo Hospital (DCH CMH). Objective To study the prevalence of primary hypothyroidism in thalassemia major patients in the Thalassemia Center, DCH MCH. Methods We performed a cross-sectional, descriptive study. All thalassemia major subjects aged 0-18 years with severe iron overload underwent thyroid function examination. Primary hypothyroidism was defined as either normal (compensated) or decreased (decompensated) free T4 (FT4) levels, along with elevated sensitive thyroid-stimulating hormone (TSH) Results 179 subjects enrolled this study with male: female ratio of 1:1.6. The prevalence of primary hypothyroidism in thalassemia major patients with severe iron overload was 26.8% (48/179). Of those 48, 45 had compensated hypothyroidism and 3 had decompensated hypothyroidism, 25.1% and 1.7% of the total subjects, respectively. Compensated hypothyroidism was observed in 17 subjects aged <10 years and in 28 subjects aged >10 years. All 3 decompensated hypothyroidism cases were > 10 years of age. No relationship was found between the occurrence of primary hypothyroidism and mean pre-transfusion Hb levels (P=0.481, OR 1.30; 95% CI 0.63 to 2.68), elevated serum ferritin levels (P-0.74, OR a89; 95% CI 0.46 to L75), and compliance to iron chelation therapy (P=0.570, OR 0.76; 95% CI 0.35 to 1.65). Based on multivariate analysis, only age of < 10 year-old (P=0.029, OR 0.469; 95% CI 0.23 to 0.93) was significantly associated with primary hypothyroidism. Further analysis using receiver operator curve (ROC) technique found that age of 8.5 year-old was the cutoff value to predict the risk of hypothyroidism. Conclusion The prevalence of primary hypothyroidism in our study is high. The occurrence of hypothyroidism is associated with age.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [1] PROGRESSIVE DYSFUNCTION OF MONOCYTES ASSOCIATED WITH IRON OVERLOAD AND AGE IN PATIENTS WITH THALASSEMIA MAJOR
    BALLART, IJ
    ESTEVEZ, ME
    SEN, L
    DIEZ, RA
    GIUNTOLI, J
    DEMIANI, SA
    PENALVER, J
    BLOOD, 1986, 67 (01) : 105 - 109
  • [2] Value of severe liver iron overload for assessing heart iron levels in thalassemia major patients
    Chen, Xiaodong
    Zhang, Hui
    Yang, Qihua
    Luo, Zebin
    Zhang, Zuoquan
    Cheng, Ziliang
    Mao, Jiaji
    Chan, Queenie
    Xu, Honggui
    Liang, Biling
    Guo, Hua
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2016, 44 (04) : 880 - 889
  • [3] Endocrine Dysfunctions in Iron Overload in Patients with Major Thalassemia
    Hashemi, A.
    Hashemian, Z.
    Ordooei, M.
    Amanat, M.
    Purshamsi, F.
    Ghasemi, N.
    Eslami, Z.
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2012, 2 (02) : 60 - 66
  • [4] Iron overload and antioxidant status in patients with β-thalassemia major
    Reller, K
    Dresow, B
    Collell, M
    Fischer, R
    Engelhardt, R
    Nielsen, P
    Dürken, M
    Politis, C
    Piga, A
    COOLEYS ANEMIA: SEVENTH SYMPOSIUM, 1998, 850 : 463 - 465
  • [5] Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients
    Shaw, Jyoti
    Chakraborty, Ayan
    Nag, Arijit
    Chattopadyay, Arnab
    Dasgupta, Anjan K.
    Bhattacharyya, Maitreyee
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (05) : 399 - 408
  • [6] DETECTION OF EARLY CARDIAC DYSFUNCTION IN PATIENTS WITH SEVERE BETA-THALASSEMIA AND CHRONIC IRON OVERLOAD
    LEON, MB
    BORER, JS
    BACHARACH, SL
    GREEN, MV
    BENZ, EJ
    GRIFFITH, P
    NIENHUIS, AW
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (21): : 1143 - 1148
  • [7] Combination Therapy of Deferasirox and Deferoxamine As Paregoric Treatment of Severe Iron Overload in Patients with Thalassemia Major
    Ladis, Vassilis
    Kyriacopoulou, Dimitra
    Stokidis, Konstantinos
    Moira, Aggeliki
    Kattamis, Antonios
    BLOOD, 2012, 120 (21)
  • [8] THALASSEMIA MAJOR - PROBLEM OF IRON OVERLOAD
    STOCKMAN, JA
    OSKI, FA
    ANNALS OF INTERNAL MEDICINE, 1974, 81 (02) : 262 - 263
  • [9] Treatment of cardiac iron overload in thalassemia major
    Westwood, M
    Anderson, LJ
    Pennell, DJ
    HAEMATOLOGICA, 2003, 88 (05) : 481 - 482
  • [10] EFFICACY OF DEFEROXAMINE IN PREVENTING COMPLICATIONS OF IRON OVERLOAD IN PATIENTS WITH THALASSEMIA MAJOR
    BRITTENHAM, GM
    GRIFFITH, PM
    NIENHUIS, AW
    MCLAREN, CE
    YOUNG, NS
    TUCKER, EE
    ALLEN, CJ
    FARRELL, DE
    HARRIS, JW
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (09): : 567 - 573